Data from EMC - Curated by EPG Health - Last updated 19 August 2016

Indication(s)

Consideration should be given to official guidance on the appropriate use of antibacterial agents.

Nebcin is indicated for the treatment of the following infections caused by susceptible micro-organisms:

Central nervous system infections, including meningitis, septicaemia and neonatal sepsis

Gastro-intestinal infections, including peritonitis, and other significant infections such as complicated and recurrent urinary tract infections, including pyelonephritis and cystitis

Lower respiratory tract infections, including pneumonia, bronchopneumonia and acute bronchitis

Skin, bone and soft tissue infections, including burns

Nebcin may be considered in serious staphylococcal infections for which penicillin or other less potentially toxic drugs are contra-indicated and when bacterial susceptibility testing and clinical judgement indicate its use.

 

Full Prescribing information

Learning Zones

An epgonline.org Learning Zone (LZ) is an area of the site dedicated to providing detailed self-directed medical education about a disease, condition or procedure.

Fluid Management

Fluid Management

Are you up-to-date with the latest evidence of effective procedures for fluid management?

+ 2 more

Inflammatory bowel disease assessment tools

Inflammatory bowel disease assessment tools

'New IBD assessment tools at a glance' - an educational symposium sponsored by Sandoz.

Sleep Apnea

Sleep Apnea

Sleep apnea is a chronic condition characterised by recurrent interruptions in breathing throughout the sleep cycle. Learn about the two main types of sleep apnea and hear from experts as they present the latest research at the Sleep and Breathing conference (Marseille, 2019).

Load more

Related Content

More information

Category Value
Orphan designation No
Type POM
Marketing authorisation holder Flynn Pharma Ltd